S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:FNJN

Finjan (FNJN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.54
$1.54
50-Day Range
$1.54
$1.54
52-Week Range
$0.75
$2.39
Volume
N/A
Average Volume
145,068 shs
Market Capitalization
$42.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
FNJN stock logo

About Finjan Stock (NASDAQ:FNJN)

Finjan Holdings, Inc., a cybersecurity company, provides intellectual property licensing and enforcement services in the United States and internationally. The company owns a portfolio of patents related to software and hardware technologies that proactively detect malicious code and thereby protects end users from identity and data theft, spyware, malware, phishing, Trojans, and other Web and network threats. Its patented technologies are used in specific cybersecurity technology areas, including endpoint/cloud software, Web gateway/Internet infrastructure, networking equipment markets, and mobile security. The company's technology scans and repels the latest and unknown threats to network, Web, and endpoint devices on a real-time basis. It also develops mobile security applications; and invests in cybersecurity technologies and intellectual property. Finjan Holdings, Inc. was founded in 1997 and is headquartered in East Palo Alto, California.

FNJN Stock News Headlines

Finjan Holdings, Inc. News
FNJN_old Historical Data
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
See More Headlines
Receive FNJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Finjan and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2020
Today
4/19/2024

Industry, Sector and Symbol

Industry
Patent Owners & Lessors
Sub-Industry
N/A
Current Symbol
NASDAQ:FNJN
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-16,490,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$13.15 million
Book Value
$1.42 per share

Miscellaneous

Free Float
N/A
Market Cap
$42.66 million
Optionable
Optionable
Beta
0.95
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Philip Hartstein (Age 43)
    Pres & CEO
  • Mr. Michael D. Noonan (Age 60)
    CFO, Treasurer & Sec.
  • Ms. Julie Mar-Spinola (Age 62)
    Chief Intellectual Property Officer & VP of Legal Operations
  • Ms. Vanessa Winter
    Director of Investor Relations & Corp. Communications
  • Ms. Rebecca Galdos
    Mang. of Office & HR

FNJN Stock Analysis - Frequently Asked Questions

How were Finjan's earnings last quarter?

Finjan Holdings, Inc. (NASDAQ:FNJN) posted its quarterly earnings results on Wednesday, May, 13th. The software maker reported ($0.15) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.15). The software maker had revenue of $3.80 million for the quarter, compared to the consensus estimate of $3.80 million.

What other stocks do shareholders of Finjan own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Finjan investors own include OPKO Health (OPK), DURECT (DRRX), (HCLP) (HCLP), Stage Stores (SSI), Energous (WATT), Advanced Micro Devices (AMD), Corus Entertainment (CJREF), Checkpoint Therapeutics (CKPT), AT&T (T) and Applied Materials (AMAT).

This page (NASDAQ:FNJN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners